Skip to main content
. 2020 Apr 9;10:140. doi: 10.3389/fcimb.2020.00140

Table 1.

Patient characteristics.

Variables Anti-free (n = 20) Control (n = 20) NEC (n = 20) *P-value
Age, (x ± s) day 11.80 ± 6.60 12.35 ± 6.59 12.45 ± 6.72 0.265
GA, (x ± s) week 37.85 ± 2.35 37.65 ± 2.25 37.60 ± 2.62 0.17
Male, % (n) 55% (11) 55% (11) 11/9 1
Breast feeding, % (n) 20% (4) 15% (3) 10% (2) 0.38/0.63
Vaginal delivery, % (n) 40% (8) 40% (8) 40% (8) 1
Procalcitonin M (P25, P75) ng/ml 0.08 (0.06, 0.10) 0.34 (0.10, 3.34) 1.47 (0.09, 15.68) 0.00
CRP > 8 mg/L, % (n)* 0% (0) 45% (9) 50% (10) 0.00
Bloody stool, % (n) 0% (0) 0% (0) 80% (16) 0.00
Vomiting 0% (0) 0% (0) 30% (6) 0.00
Intrahepatic or portal venous gas, % (n) 0% (0) 0% (0) 100% (20) 0.00
*

CRP, C-reactive protein.